Neurochemical aspects on aging and diseases with cognitive impairment

CG Gottfries - Journal of neuroscience research, 1990 - Wiley Online Library
The concentrations of monoamines and cholineacetyl transferase (CAT) are reduced in
brains from patients with normal aging. According to findings about the dopamine (DA) …

Functional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate

K Shirbandi, R Rikhtegar, M Khalafi… - Topics in Magnetic …, 2023 - journals.lww.com
Functional 1H magnetic resonance spectroscopy (fMRS) is a derivative of dynamic MRS
imaging. This modality links physiologic metabolic responses with available activity and …

Lignan-Rich Sesame (Sesamum indicum L.) Cultivar Exhibits In Vitro Anti-Cholinesterase Activity, Anti-Neurotoxicity in Amyloid-β Induced SH-SY5Y Cells, and …

MY Kim, S Kim, J Lee, JI Kim, E Oh, SW Kim, E Lee… - Antioxidants, 2023 - mdpi.com
Alzheimer's disease, a major cause of dementia, is characterized by impaired cholinergic
function, increased oxidative stress, and amyloid cascade induction. Sesame lignans have …

Neuromodulatory potential of Asparagus racemosus and its bioactive molecule Shatavarin IV by enhancing synaptic acetylcholine level and nAChR activity

SS Smita, M Trivedi, D Tripathi, S Pandey-Rai… - Neuroscience …, 2021 - Elsevier
Cholinergic dysfunction has been commonly known to be associated with plethora of
neurodegenerative disorders and also serves as a biomarker. Recently, cholinergic system …

Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders

CG Trolin, B Regland, L Oreland - European Neuropsychopharmacology, 1995 - Elsevier
ATP: l-methionine S-adenosyltransferase (EC 2.5. 1.6, MAT) activity was analyzed in
erythrocytes from nine patients with a clinical diagnosis of probable Alzheimer's disease …

Protective Roles of Melatonin in Alzheimer's Disease: A Review of Experimental and Clinical Research

G Davodi-Boroujerdi, AK Naghadehi… - Jentashapir Journal of …, 2024 - brieflands.com
: Alzheimer's disease (AD) stands as the most prevalent neurodegenerative disorder,
marked by neuronal loss, synaptic dysfunction, atrophy in various brain regions, cognitive …

Pharmacological treatment strategies in Alzheimer type dementia

CG Gottfries - European Neuropsychopharmacology, 1990 - Elsevier
Substitution of cholinergic drugs in the treatment of Alzheimer type dementia (AD/SDAT) has
hitherto not been very successful. Accumulating data indicate that monoamines are …

Review of treatment strategies.

CG Gottfries - Acta Neurologica Scandinavica, 1992 - psycnet.apa.org
Outlines the pharmacological treatment strategies that can be directly related to the
assumed pathophysiology of dementia of the Alzheimer type (DAT). Central-stimulating …

Effects of an inhibitor of GABA-aminotransferase (γ-vinyl-GABA) on the spatial navigation deficit induced by muscarinic blockade

M Mazurkiewicz, J Sirviö, PJ Riekkinen - Pharmacology Biochemistry and …, 1992 - Elsevier
The present study investigated whether stimulation of the GABAergic system affects spatial
navigation [water-maze (WM)] deficit induced by muscarinic blockade (scopolamine). The …

[PDF][PDF] ВОЗМОЖНОСТИ ХОЛИНЕРГИЧЕСКОй ТЕРАПИИ У ПОЖИЛЫХ ПАЦИЕНТОВ С МЯГКИМ КОГНИТИВНЫМ СНИЖЕНИЕМ

ЕВ Пономарева - ИзвестИя РоссИйской военно-медИцИнской … - medum.org
В статье представлена сравнительная оценка динамики показателей когнитивного
функционирования на протяжении годового наблюдения в 3 группах пожилых …